Literature DB >> 6115785

Glucose disposal is not proportional to plasma glucose level in man.

J D Best, G J Taborsky, J B Halter, D Porte.   

Abstract

Metabolic clearance rate (MCR) of glucose has been defined as the rate of glucose utilization divided by the glucose concentration. This model of glucose transport has been widely used as a measure of hormonally regulated glucose disposal, on the assumption that glucose disposal rate is proportional to glucose concentration. To test this assumption, the relationship between glucose concentration and disposal rate was studied in man during infusion of somatostatin +/- exogenous insulin to achieve fixed plasma insulin levels of 1, 18, and 46 microM/ml on separate days. When glucose concentration was increased to more than twice basal fasting levels, the glucose disposal rate increased significantly at all three insulin levels. However, the increase was not proportional to the rise in glucose concentration, and MCR fell by 38%, 16%, and 11% at the low, medium, and high insulin levels, respectively. These results are explained by an alternative model of glucose transport in which insulin-independent tissues such as brain have a relatively fixed glucose uptake, while other tissues have glucose transport systems which take up glucose at a rate proportional to its plasma concentration. We conclude that MCR of glucose is not a good measure of hormonally regulated glucose disposal because it is partially dependent on the glucose concentration, particularly at low insulin levels.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6115785     DOI: 10.2337/diab.30.10.847

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  31 in total

1.  New ways in which GLP-1 can regulate glucose homeostasis.

Authors:  David A D'Alessio; Darleen A Sandoval; Randy J Seeley
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

2.  Familiality of physical and metabolic characteristics that predict the development of non-insulin-dependent diabetes mellitus in Pima Indians.

Authors:  H Sakul; R Pratley; L Cardon; E Ravussin; D Mott; C Bogardus
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

3.  Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration.

Authors:  S R Myers; O P McGuinness; D W Neal; A D Cherrington
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

4.  Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance.

Authors:  A Basu; A Alzaid; S Dinneen; A Caumo; C Cobelli; R A Rizza
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

5.  Development of a clinical type 1 diabetes metabolic system model and in silico simulation tool.

Authors:  Xing-Wei Wong; J Geoffrey Chase; Christopher E Hann; Thomas F Lotz; Jessica Lin; Aaron J Le; Geoffrey M Shaw
Journal:  J Diabetes Sci Technol       Date:  2008-05

Review 6.  Insulin resistance and impaired lipid metabolism as a potential link between diabetes and Alzheimer's disease.

Authors:  Joshua A Kulas; Thaddeus K Weigel; Heather A Ferris
Journal:  Drug Dev Res       Date:  2020-02-05       Impact factor: 4.360

7.  Insulin resistance associated with lower rates of weight gain in Pima Indians.

Authors:  B A Swinburn; B L Nyomba; M F Saad; F Zurlo; I Raz; W C Knowler; S Lillioja; C Bogardus; E Ravussin
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 8.  The metabolic clearance of glucose: measurement and meaning.

Authors:  J Radziuk; H L Lickley
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

9.  Effect of ketone bodies on glucose production and utilization in the miniature pig.

Authors:  M J Müller; U Paschen; H J Seitz
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

10.  Derivation of a quantitative measure of insulin sensitivity from the intravenous tolbutamide test using the minimal model of glucose dynamics.

Authors:  N M Shennan; I F Godsland; V Wynn
Journal:  Diabetologia       Date:  1987-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.